Lipocine Ownership | Who Owns Lipocine?


OverviewForecastRevenueFinancialsChart

Lipocine Ownership Summary


Lipocine is owned by 8.49% institutional investors, 2.84% insiders, and 88.67% retail investors. Vanguard group is the largest institutional shareholder, holding 4.10% of LPCN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.64% of its assets in Lipocine shares.

LPCN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLipocine8.49%2.84%88.67%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group221.87K4.10%$1.78M
Blackrock funding, inc. /de89.27K1.65%$716.85K
Mink brook asset management66.81K1.23%$533.83K
Geode capital management62.45K1.15%$501.54K
Renaissance37.40K0.69%$300.30K
State street18.63K0.35%$53.27K
Northern trust13.16K0.25%$37.51K
Dimensional fund advisors lp12.14K0.22%$97.48K
Jane street group10.57K0.20%$84.91K
Ubs group5.60K0.10%$44.99K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mink brook asset management66.81K0.30%$533.83K
Caldwell sutter capital471.000.00%$3.78K
Renaissance37.40K0.00%$300.30K
Highmark wealth management100.000.00%$803.00
Tower research capital llc (trc)1.17K0.00%$3.33K
Tidemark59.000.00%$474.00
Jane street group10.57K-$84.91K
Advisor group2.27K-$6.46K
Northern trust13.16K-$37.51K
Barclays---

Top Buyers

HolderShares% AssetsChange
Mink brook asset management66.81K0.30%66.81K
Jane street group10.57K-10.57K
Ubs group5.60K-3.84K
Geode capital management62.45K-1.37K
Renaissance37.40K0.00%1.30K

Top Sellers

HolderShares% AssetsChange
Barclays---9.41K
Advisor group2.27K--19.00
Jpmorgan chase---11.00
Citigroup---3.00
Tidemark59.000.00%-

New Positions

HolderShares% AssetsChangeValue
Mink brook asset management66.81K0.30%66.81K$533.83K
Jane street group10.57K-10.57K$84.91K
Highmark wealth management100.000.00%100.00$803.00
Farther finance advisors1.00-1.00$9.00

Sold Out

HolderChange
Citigroup-3.00
Jpmorgan chase-11.00
Barclays-9.41K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202514-33.33%459,539-13.18%88.68%6-14.29%--100.00%
Sep 30, 20252116.67%529,3070.16%910.14%716.67%4-33.33%
Jun 30, 202518-5.26%528,3562.10%910.55%5-54.55%7133.33%
Mar 31, 20251911.76%517,4736.33%911.64%11120.00%3-25.00%
Dec 31, 202417-5.56%486,671-10.62%98.79%5-50.00%4-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF141.08K2.64%-
Vanguard Total Stock Mkt Idx Inv142.77K1.96%-
Vanguard Institutional Extnd Mkt Idx Tr57.90K0.79%-
Fidelity Extended Market Index28.60K0.39%-104.00
Vifag 2002 SICAV17.77K0.33%-
BlackRock Extended Equity Market K12.86K0.24%-5.00
Extended Equity Market Fund E14.75K0.20%-
Extended Equity Market Fund B14.75K0.20%-
Blackrock Extended Mkt Fund CF14.75K0.20%-
Extended Equity Market Fund K12.56K0.17%-92.00

Recent Insider Transactions


DateNameRoleActivityValue
Apr 07, 2026Higuchi John W.-Buy$81.20K
Apr 06, 2026Higuchi John W.-Buy$252.15K
Apr 06, 2026Patel Mahesh V. Chief Executive OfficerBuy$50.75K
Apr 02, 2026Patel Mahesh V. Chief Executive OfficerBuy$50.50K
May 25, 2023Patel Mahesh V. CEO and PresidentBuy$43.79K

Insider Transactions Trends


DateBuySell
2026 Q23-
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--

LPCN Ownership FAQ


Who Owns Lipocine?

Lipocine shareholders are primarily institutional investors at 8.49%, followed by 2.84% insiders and 88.67% retail investors. The average institutional ownership in Lipocine's industry, Biotech Stocks , is 382.13%, which Lipocine falls below.

Who owns the most shares of Lipocine?

Lipocine’s largest shareholders are Vanguard group (221.87K shares, 4.10%), Blackrock funding, inc. /de (89.27K shares, 1.65%), and Mink brook asset management (66.81K shares, 1.23%). Together, they hold 6.97% of Lipocine’s total shares outstanding.

Does Blackrock own Lipocine?

BlackRock is not among the top 10 institutional shareholders of Lipocine.

Who is Lipocine’s biggest shareholder by percentage of total assets invested?

Mink brook asset management is Lipocine’s biggest shareholder by percentage of total assets invested, with 0.30% of its assets in 66.81K Lipocine shares, valued at 533.83K$.

Who is the top mutual fund holder of Lipocine shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Lipocine shares, with 2.64% of its total shares outstanding invested in 141.08K Lipocine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools